Please provide your email address to receive an email when new articles are posted on . Pars plana vitrectomy with subretinal tissue plasminogen activator injection led to significant vision ...

To investigate the efficacy of gravitational displacement following vitrectomy for the patients with submacular haemorrhage (SMH) secondary to age-related macular degeneration (AMD). Retrospective, ...

Finding all retinal breaks is a critical step in rhegmatogenous retinal detachment (RRD) surgery in order to prevent persistent/recurrent retinal detachment (RD). We describe a technique of ...

“Currently, there is a lack of evidence-based research and rigorous guidelines for the management of patients with SMH secondary to nAMD [neovascular AMD],” said Dr. Gabrielle, who is based at the ...

LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced that the first surgery using its proprietary Orbit™ Subretinal Delivery System ...

Please provide your email address to receive an email when new articles are posted on . Early treatment of diabetic macular edema with pars plana vitrectomy yielded positive vision improvements. The ...

These images are the results of a subretinal injection. Left is the image of the injection site in the retina, the green box indicates the plane in which the right image was taken. Right is the ...

A vitrectomy is the surgical procedure for treating diabetic retinopathy. Surgery is aimed at getting better access to your retina to improve or stop vision loss from this diabetes complication.

A vitrectomy is a type of eye surgery. An eye doctor may recommend it to treat advanced diabetic retinopathy. The surgery involves removing blood and scar tissue in the eye. Diabetic retinopathy can ...

Researchers reported few adverse events among pediatric X-linked retinoschisis patients who received a single, photoreceptor cell-targeted gene therapy dose.